Men’s health start-up Numan has acquired Vi-Health, a medical science and healthcare technology company based in Sweden, as it continues its development as a consumer healthcare provider.
Vi Health’s platform is registered as a Class I Medical Device and includes an AI-powered symptom checker, advanced e-consultation tools such as collaborative chat, voice and video consultations, and workflow automation tools.
Vi-Health says that used together these tools have been shown to reduce the workload faced by a clinical team by up to 70 per cent, in trials run by the company in Sweden.
The majority of the Vi-Health team will also be joining Numan, while continuing to work from their offices in Stockholm and Malmö.
Numan combines prescription medication and proprietary OTC products, pathology and screening, along with doctor consultations. Since 2019 it has helped 150,000 patients and recruited 300,000 men to its platform, who in total have engaged in 1.4m digital consultations.
Sokratis Papafloratos, founder and CEO of Numan, says: “Vi-health is an exceptional company and was the perfect fit for us in terms of vision, IP and skills. The team was a big driver behind our decision to make the acquisition. It’s a group of people full of talent, deep expertise, and a passion about changing healthcare for the better, on a global scale. We’re all very excited to be working together.”